The top brass at American Express, chagrined at the discovery of its people tracking plans, met with CASPIAN (Consumers Against Supermarket Privacy Invasion and Numbering) last week to discuss the issue. One outcome of the meeting was a promise by American Express to review its entire patent portfolio and ensure that any people-tracking plans be accompanied by language requiring consumer notice and consent.

“Long-range RFID is meant for tracking packages in a warehouse,” says Randy Vanderhoof, executive director of the Smart Card Alliance, which has been tracking the laws and technology proposals for what DHS and Congress call the Western Hemisphere Travel Initiative (WHTI), part of the many security revisions hammered out in the wake of the Sept. 11 terrorist attacks six years ago.

The report reveals how news outlets like Time Magazine, Business Week, and the RFID Journal were used as unwitting pawns in a VeriChip scheme to spread misinformation about the cancer studies. Since research linking the product to cancer first surfaced last year, each of these publications has repeated misstatements from VeriChip company executives, in many cases printing the inaccurate statements verbatim and unchallenged.

When the U.S. Food and Drug Administration approved implanting microchips in humans, the manufacturer said it would save lives, letting doctors scan the tiny transponders to access patients’ medical records almost instantly. The FDA found “reasonable assurance” the device was safe, and a sub-agency even called it one of 2005’s top “innovative
technologies.”

But neither the company nor the regulators publicly mentioned this: A series of veterinary and toxicology studies, dating to the mid-1990s, stated that chip implants had “induced” malignant tumors in some lab mice and rats.

“Your ID, please” is a phrase Americans will be hearing far more often if the Real ID Act is implemented. But with your help today, we can prevent this ‘Real Nightmare’ from becoming a reality.